Strategic PartnershipMCA & GST VerifiedHigh ROI Asset
Project US-109
US-FDA & WHO-GMP Certified Solid Oral Formulation Plant in Jaipur
22% EBITDA Margins • ₹49.37 Cr ARR • Turnkey Operation
Healthcare & PharmaJaipur, RajasthanEst. 2014 (12 yrs)87 Staff27 views today
93% AI Match ScoreStrong Health
Asking Valuation
₹36.93 Cr3.4x EBITDA
Annual Revenue₹49.37 Cr
EBITDA₹10.86 Cr
EBITDA Margin22%
Net Profit₹7.82 Cr
Representation:Verified Founder / Promoter
Advisor Response Rate:Under 2 Hours
Audited Documents:23 Confidential Files
Executive Summary
Highly profitable and established Healthcare & Pharma enterprise operating out of Jaipur, Rajasthan. Established in 2014, the company has built a pristine client base, deep operating moats, and verified audited books.
Key Investment Highlights & Competitive Moats
Audited FY25-26 revenue of ₹49.37 Cr with verified 22% EBITDA margins
Pristine compliance history with clean GST, MCA, and Income Tax records
48000 sq.ft (Long-Term Leased) modern facility fully equipped with compliant infrastructure
Experienced senior management team remaining post-acquisition for seamless transition
Identified Growth Corridors & Upside Potential
Expansion into Tier-1 export corridors and digital marketplace channels
Capacity utilization currently at 65%, offering immediate upside with existing fixed assets
Strategic synergies for synergistic corporate acquirers and PE roll-up platforms
Hard Assets, Real Estate & IP Included in Sale
- All plant machinery, tools, and compliant operating equipment
- Brand trademarks, proprietary customer contracts, and supplier databases
- Working capital transition support and transfer of operating licenses
Reason for Divestment / Capital Raise
Seeking strategic institutional partner for pan-India expansion
Similar Verified Opportunities
Curated deals matching similar industry and EBITDA parameters.
Healthcare & Pharma
Hot Deal
Verified
Indore, Madhya PradeshEst. 2015
Diagnostic Lab Chain & Pathology Network across 14 Centers in Indore
23% EBITDA Margins • ₹54.93 Cr ARR • Turnkey Operation
Asking Price₹48.01 Cr
Revenue₹54.93 Cr
EBITDA23%
Healthcare & Pharma
Hot Deal
Verified
Coimbatore, Tamil NaduEst. 2016
NABH-Accredited 75-Bed Multi-Specialty Surgical Hospital in Coimbatore
24% EBITDA Margins • ₹59.12 Cr ARR • Turnkey Operation
Asking Price₹59.60 Cr
Revenue₹59.12 Cr
EBITDA24%
Healthcare & Pharma
Hot Deal
Verified
Chandigarh, PunjabEst. 2017
API & Intermediates Chemical Synthesis Manufacturing Unit in Chandigarh
25% EBITDA Margins • ₹63.85 Cr ARR • Turnkey Operation
Asking Price₹35.12 Cr
Revenue₹63.85 Cr
EBITDA25%